Phesgo 30000 U/15mL
pertuzumab, trastuzumab, and hyaluronidase-zzxf · INJECTION, SOLUTION · Genentech, Inc.
Phesgo is a injection, solution containing pertuzumab, trastuzumab, and hyaluronidase-zzxf at 30000 U/15mL, taken subcutaneous. Manufactured by Genentech, Inc..
Key Facts
- Brand Name
- Phesgo
- Generic Name
- pertuzumab, trastuzumab, and hyaluronidase-zzxf
- NDC Code (Product)
50242-245- Manufacturer
- Genentech, Inc.
- Strength
- 30000 U/15mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761170
- Drug Class
- Endoglycosidase [EPC]; HER2/neu Receptor Antagonist [EPC]
- Marketing Start
- 06/29/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is Phesgo used for?
Phesgo contains pertuzumab, trastuzumab, and hyaluronidase-zzxf. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Phesgo a controlled substance?
Phesgo is not classified as a controlled substance by the DEA.
What is the generic name for Phesgo?
The generic name for Phesgo is pertuzumab, trastuzumab, and hyaluronidase-zzxf. There are no other listed brand versions of pertuzumab, trastuzumab, and hyaluronidase-zzxf.
What is the NDC code for Phesgo 30000 U/15mL?
The NDC (National Drug Code) for Phesgo 30000 U/15mL is 50242-245, listed by Genentech, Inc..
Other Phesgo Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)